In Part I, we described the overall approach under the category of AugI, and then focused on recent successes in treating cancer. In Part II, we will shift to related work, still under AugI, in treating autoimmune diseases - a class that has essentially been considered incurable, at least until now.
Get Access
Speak With Representative
Access this content by contacting one of our representatives for assistance.
Mark Anderson
Research Fellow
Mark Anderson writes the most accurate predictive reports covering the computing and communication industries. His weekly Trends and Predictions posts cover must-have information for strategy development and business technology planning, and are followed by technology executives and investors worldwide including Bill Gates, Paul Jacobs, Michael Dell and more.
Download Sample Article